Risk of cholangiocarcinoma in patients undergoing therapeutic endoscopic retrograde cholangiopancreatography or cholecystectomy: A population based study

doi:10.4251/wjgo.v11.i3.238

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9790)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

395

WORD

230

HTML

4158

Figures (1-2)

235

Tables (1-3)

243

Sum=5261

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

799

Download

959

Sum=1758

Publishing Process of This Article

Item

Count

Browse

957

Download

1814

Sum=2771

Mar 15, 2019 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastrointest Oncol. Mar 15, 2019; 11(3): 238-249
Published online Mar 15, 2019. doi: 10.4251/wjgo.v11.i3.238

Open in New Tab Full Size Figure Download Figure

Figure 1 Case selection flow chart of one million nationwide representative data base. ES/EPBD: Endoscopic sphincterotomy/endoscopic papillary balloon dilatation; NHIRD: National Health Insurance Research Database.

Open in New Tab Full Size Figure Download Figure

Figure 2 Cumulative risk of cholangiocarcinoma. The cases of cholangiocarcinoma within 6 mo after the therapeutic procedure or the diagnosis of cholelithiasis were excluded. ES/EPBD: Endoscopic sphincterotomy/endoscopic papillary balloon dilatation.

Citation: Wang CC, Tsai MC, Sung WW, Yang TW, Chen HY, Wang YT, Su CC, Tseng MH, Lin CC. Risk of cholangiocarcinoma in patients undergoing therapeutic endoscopic retrograde cholangiopancreatography or cholecystectomy: A population based study. World J Gastrointest Oncol 2019; 11(3): 238-249
URL: https://www.wjgnet.com/1948-5204/full/v11/i3/238.htm
DOI: https://dx.doi.org/10.4251/wjgo.v11.i3.238